Erythrodermic Psoriasis Exacerbated by Bupropion

Erythroderma is a rare, potentially life-threatening presentation of psoriasis that can be triggered by medication reactions. Bupropion is indicated for major depressive disorder (Wellbutrin®, GlaxoSmithKline, Research Triangle Park, NC), smoking cessation (Zyban®, GlaxoSmithKline, Research Triangle...

Descripción completa

Detalles Bibliográficos
Autores principales: Foss, Michael G, Nyckowski, Timothy, Steffes, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563139/
https://www.ncbi.nlm.nih.gov/pubmed/34745784
http://dx.doi.org/10.7759/cureus.18460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563139/
https://www.ncbi.nlm.nih.gov/pubmed/34745784
http://dx.doi.org/10.7759/cureus.18460

Ejemplares similares